Reviewing Cogentix Medical (CGNT) & Mindray Medical International (MR)
Cogentix Medical (NASDAQ: CGNT) and Mindray Medical International (NYSE:MR) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.
Insider and Institutional Ownership
13.3% of Cogentix Medical shares are held by institutional investors. 62.7% of Cogentix Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Mindray Medical International pays an annual dividend of $0.36 per share and has a dividend yield of 1.3%. Cogentix Medical does not pay a dividend. Mindray Medical International pays out 24.2% of its earnings in the form of a dividend.
This table compares Cogentix Medical and Mindray Medical International’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Mindray Medical International||15.93%||12.70%||8.37%|
This is a breakdown of recent ratings and recommmendations for Cogentix Medical and Mindray Medical International, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Mindray Medical International||0||0||0||0||N/A|
Cogentix Medical currently has a consensus price target of $4.58, indicating a potential upside of 61.38%. Given Cogentix Medical’s higher possible upside, equities analysts plainly believe Cogentix Medical is more favorable than Mindray Medical International.
Valuation & Earnings
This table compares Cogentix Medical and Mindray Medical International’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Cogentix Medical||$51.85 million||3.34||-$22.09 million||($0.41)||-6.93|
|Mindray Medical International||N/A||N/A||N/A||$1.49||18.75|
Mindray Medical International has lower revenue, but higher earnings than Cogentix Medical. Cogentix Medical is trading at a lower price-to-earnings ratio than Mindray Medical International, indicating that it is currently the more affordable of the two stocks.
Cogentix Medical beats Mindray Medical International on 6 of the 11 factors compared between the two stocks.
Cogentix Medical Company Profile
Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.
Mindray Medical International Company Profile
Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.
Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.